271 related articles for article (PubMed ID: 38399960)
1. Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness.
Liu W; Huang Z; Xiao J; Wu Y; Xia N; Yuan Q
Viruses; 2024 Jan; 16(2):. PubMed ID: 38399960
[TBL] [Abstract][Full Text] [Related]
2. Structural Basis for the Enhanced Infectivity and Immune Evasion of Omicron Subvariants.
Li Y; Shen Y; Zhang Y; Yan R
Viruses; 2023 Jun; 15(6):. PubMed ID: 37376697
[TBL] [Abstract][Full Text] [Related]
3. Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
Jung C; Kmiec D; Koepke L; Zech F; Jacob T; Sparrer KMJ; Kirchhoff F
J Virol; 2022 Mar; 96(6):e0207721. PubMed ID: 35225672
[TBL] [Abstract][Full Text] [Related]
4. Unique mutations in SARS-CoV-2 Omicron subvariants' non-spike proteins: Potential impacts on viral pathogenesis and host immune evasion.
Hossain A; Akter S; Rashid AA; Khair S; Alam ASMRU
Microb Pathog; 2022 Sep; 170():105699. PubMed ID: 35944840
[TBL] [Abstract][Full Text] [Related]
5. Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2.
Pastorio C; Zech F; Noettger S; Jung C; Jacob T; Sanderson T; Sparrer KMJ; Kirchhoff F
Cell Host Microbe; 2022 Sep; 30(9):1255-1268.e5. PubMed ID: 35931073
[TBL] [Abstract][Full Text] [Related]
6. Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant.
Ren W; Zhang Y; Rao J; Wang Z; Lan J; Liu K; Zhang X; Hu X; Yang C; Zhong G; Zhang R; Wang X; Shan C; Ding Q
mBio; 2023 Apr; 14(2):e0041623. PubMed ID: 37010428
[TBL] [Abstract][Full Text] [Related]
7. Structural evolution of SARS-CoV-2 omicron in human receptor recognition.
Zhang W; Shi K; Geng Q; Herbst M; Wang M; Huang L; Bu F; Liu B; Aihara H; Li F
J Virol; 2023 Aug; 97(8):e0082223. PubMed ID: 37578233
[TBL] [Abstract][Full Text] [Related]
8. Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Dhawan M; Saied AA; Mitra S; Alhumaydhi FA; Emran TB; Wilairatana P
Biomed Pharmacother; 2022 Oct; 154():113522. PubMed ID: 36030585
[TBL] [Abstract][Full Text] [Related]
9. The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages.
Xiang T; Wang J; Zheng X
Virol Sin; 2022 Dec; 37(6):786-795. PubMed ID: 36427646
[TBL] [Abstract][Full Text] [Related]
10. Spike protein of SARS-CoV-2 Omicron variant: An
Jimenez Ruiz JA; Lopez Ramirez C; Lopez-Campos JL
Front Public Health; 2022; 10():1052241. PubMed ID: 36523581
[TBL] [Abstract][Full Text] [Related]
11. Evolution of the SARS-CoV-2 Omicron spike.
Parsons RJ; Acharya P
Cell Rep; 2023 Dec; 42(12):113444. PubMed ID: 37979169
[TBL] [Abstract][Full Text] [Related]
12. Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron.
Schröder S; Richter A; Veith T; Emanuel J; Gudermann L; Friedmann K; Jeworowski LM; Mühlemann B; Jones TC; Müller MA; Corman VM; Drosten C
Virol J; 2023 Nov; 20(1):257. PubMed ID: 37940989
[TBL] [Abstract][Full Text] [Related]
13. In Silico Genome Analysis Reveals the Evolution and Potential Impact of SARS-CoV-2 Omicron Structural Changes on Host Immune Evasion and Antiviral Therapeutics.
Chauhan D; Chakravarty N; Jeyachandran AV; Jayakarunakaran A; Sinha S; Mishra R; Arumugaswami V; Ramaiah A
Viruses; 2022 Nov; 14(11):. PubMed ID: 36366559
[TBL] [Abstract][Full Text] [Related]
14. Landscape of T cell epitopes displays hot mutations of SARS-CoV-2 variant spikes evading cellular immunity.
Gan M; Cao J; Zhang Y; Fu H; Lin X; Ouyang Q; Xu X; Yuan Y; Fan X
J Med Virol; 2024 Feb; 96(2):e29452. PubMed ID: 38314852
[TBL] [Abstract][Full Text] [Related]
15. Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics.
Kudriavtsev AV; Vakhrusheva AV; Novosеletsky VN; Bozdaganyan ME; Shaitan KV; Kirpichnikov MP; Sokolova OS
Viruses; 2022 Jul; 14(8):. PubMed ID: 35893668
[TBL] [Abstract][Full Text] [Related]
16. Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile.
Alkhatib M; Salpini R; Carioti L; Ambrosio FA; D'Anna S; Duca L; Costa G; Bellocchi MC; Piermatteo L; Artese A; Santoro MM; Alcaro S; Svicher V; Ceccherini-Silberstein F
Microbiol Spectr; 2022 Apr; 10(2):e0273221. PubMed ID: 35352942
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection.
Kurhade C; Zou J; Xia H; Liu M; Yang Q; Cutler M; Cooper D; Muik A; Sahin U; Jansen KU; Ren P; Xie X; Swanson KA; Shi PY
Emerg Microbes Infect; 2022 Dec; 11(1):1828-1832. PubMed ID: 35792746
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
[TBL] [Abstract][Full Text] [Related]
19. Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variants.
Chen L; He Y; Liu H; Shang Y; Guo G
Front Immunol; 2024; 15():1339660. PubMed ID: 38464527
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 variant biology and immune evasion.
Zaidi AK; Singh RB
Prog Mol Biol Transl Sci; 2024; 202():45-66. PubMed ID: 38237990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
